documents: FDA-2016-P-1026-0006
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-P-1026-0006 | FDA | FDA-2016-P-1026 | Medical Devices; Exemption From Premarket Notification: Method, Metallic Reduction, Glucose (Urinary, Nonquantitative) Test System in a Reagent Tablet Format | Rule | Final Rule | 2016-10-04T04:00:00Z | 2016 | 10 | 2016-10-04T04:00:00Z | 2016-10-04T16:10:04Z | 2016-23899 | 0 | 0 | 0900006482291406 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref